Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy

Kazuko Kudo, Asahito Hama, Seiji Kojima, Ruriko Ishii, Akira Morimoto, Fumio Bessho, Shosuke Sunami, Naoyuki Kobayashi, Akitoshi Kinoshita, Yuri Okimoto, Akio Tawa, Ichiro Tsukimoto

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences